Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 6, 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe SwedenAndreas Thorstenson, Ola Bratt, Olof Akre, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Prostate Cancer Radiation Therapy and Risk of Thromboembolic EventsCecilia Bosco, Hans Garmo, Jan Adolfsson, et al.
Journal of the National Cancer Institute|April 5, 2007
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall, Hans Garmo, Ove Andrén, et al.
BJUI Compass|April 27, 2022
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohortYashar Khoshkar, Marcus Westerberg, Jan Adolfsson, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
BJU International|September 24, 2017
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonistsCecilia Bosco, Chloe Wong, Hans Garmo, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
International Journal of Cancer|August 26, 2016
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Journal of Oncology|February 27, 2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base SwedenGincy George, Hans Garmo, Jan Adolfsson, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|March 6, 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe SwedenAndreas Thorstenson, Ola Bratt, Olof Akre, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Prostate Cancer Radiation Therapy and Risk of Thromboembolic EventsCecilia Bosco, Hans Garmo, Jan Adolfsson, et al.
Journal of the National Cancer Institute|April 5, 2007
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall, Hans Garmo, Ove Andrén, et al.
BJUI Compass|April 27, 2022
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohortYashar Khoshkar, Marcus Westerberg, Jan Adolfsson, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
BJU International|September 24, 2017
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonistsCecilia Bosco, Chloe Wong, Hans Garmo, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
International Journal of Cancer|August 26, 2016
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Journal of Oncology|February 27, 2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base SwedenGincy George, Hans Garmo, Jan Adolfsson, et al.
Pageof 17